Followers | 827 |
Posts | 119547 |
Boards Moderated | 15 |
Alias Born | 09/05/2002 |
Wednesday, January 11, 2017 9:49:34 AM
To trigger the 50% profit-sharing option, MNTA would have to opt in quite soon, according to CW’s statement on the 1/5/17 CC announcing the CSL deal. Under this scenario, MNTA would receive few, if any, development-based milestone payments for M230.
For the distinct 30% profit-sharing option, MNTA can opt-in at a later (undisclosed) stage of development. In this case, MNTA would get to keep any development-based milestone payments already received by the date of the opt-in.
Under either opt-in scenario, MNTA would forgo sales-based milestone payments (as you noted).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM